9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile
C37H31N5O — CID 155636196
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile
9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile (PubChem CID 155636196) has the molecular formula C37H31N5O and a molecular weight of 561.69 g/mol. Its IUPAC name is 9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile.
Molecular Properties
| Compound Name | 9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile |
|---|---|
| PubChem CID | 155636196 |
| Molecular Formula | C37H31N5O |
| Molecular Weight | 561.69 g/mol |
| Exact Mass | 561.25 |
| IUPAC Name | 9-(4-tert-butyl-2-pyridinyl)-7-[3-(3-phenyl-2H-imidazol-1-yl)phenoxy]carbazole-3-carbonitrile |
| SMILES | CC(C)(C)c1ccnc(-n2c3ccc(C#N)cc3c3ccc(Oc4cccc(N5C=CN(c6ccccc6)C5)c4)cc32)c1 |
| InChI | InChI=1S/C37H31N5O/c1-37(2,3)27-16-17-39-36(21-27)42-34-15-12-26(24-38)20-33(34)32-14-13-31(23-35(32)42)43-30-11-7-10-29(22-30)41-19-18-40(25-41)28-8-5-4-6-9-28/h4-23H,25H2,1-3H3 |
| InChIKey | OIBQXXPSMMIFGO-UHFFFAOYSA-N |
| XLogP | 8.90 |
| TPSA | 57.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 561.69 |
| LogP ≤ 5 | 8.90 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155636196 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.